<DOC>
	<DOC>NCT00095069</DOC>
	<brief_summary>The purpose of this trial is to study the safety and effectiveness of MK0928 for adults with insomnia.</brief_summary>
	<brief_title>Efficacy and Safety of MK0928 for Insomnia in Adults (0928-003)(COMPLETED)</brief_title>
	<detailed_description />
	<mesh_term>Sleep Initiation and Maintenance Disorders</mesh_term>
	<mesh_term>Gaboxadol</mesh_term>
	<criteria>Diagnosis of insomnia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>